Medical Industry
The Latest
-
CStone Shares Skyrocket Following $480 Million Pfizer Deal
CStone Pharmaceuticals stock price jumped by as much as 40 percent after it announced a deal with Pfizer worth an estimated $480 million. 
CStone Pharmaceuticals stock price jumped by as much as 40 percent after it announced a deal with Pfizer worth an estimated $480 million. -
Chinese Oncology Firm Hygeia Healthcare To List Shares In Hong Kong
Hygeia Healthcare has joined other medical firms in taking advantage of the city's increased investor interest for medical-related stocks. 
Hygeia Healthcare has joined other medical firms in taking advantage of the city's increased investor interest for medical-related stocks. -
Boehringer Ingelheim To Establish First Overseas Branch In China
The German pharmaceutical giant plans to invest up to 23.55 million yuan to set up its first overseas BI X digital laboratory in Shanghai. 
The German pharmaceutical giant plans to invest up to 23.55 million yuan to set up its first overseas BI X digital laboratory in Shanghai. -
UCB To Launch Portfolio Of Immunotherapy Treatments In China
Apart from its immunotherapy treatment for rheumatoid arthritis (RA), UCB plans to release five other treatments in China over the next five years. 
Apart from its immunotherapy treatment for rheumatoid arthritis (RA), UCB plans to release five other treatments in China over the next five years. -
Merck Buys Drug Producer ArQule In $2.7 Billion Cash Deal
Merck will be purchasing cancer drug maker ArQule for $20 per share in an all-cash deal estimated to be worth around $2.7 billion. 
Merck will be purchasing cancer drug maker ArQule for $20 per share in an all-cash deal estimated to be worth around $2.7 billion. -
Johnson & Johnson and Boao Lecheng Launches Innovation Chain In China
Johnson & Johnson, in collaboration with China's Boao Lecheng International Medical Tourism Pilot Zone, has launched its new Johnson & Johnson Boao Innovation Chain in the Boao pilot zone. 
Johnson & Johnson, in collaboration with China's Boao Lecheng International Medical Tourism Pilot Zone, has launched its new Johnson & Johnson Boao Innovation Chain in the Boao pilot zone. -
Drugmakers Investing Billions In Building Internal Gene Therapy Facilities
Since 2018, major drugmakers have invested a combined $2 billion in establishing their own gene therapy manufacturing facilities. 
Since 2018, major drugmakers have invested a combined $2 billion in establishing their own gene therapy manufacturing facilities. -
US Tariffs On Animal Test Subjects Likely To Push Research Overseas
The US' tariffs on additional Chinese imports could have an unforeseen effect on the country's biotech industry as facilities are forced to rethink their US operations. 
The US' tariffs on additional Chinese imports could have an unforeseen effect on the country's biotech industry as facilities are forced to rethink their US operations. -
Novartis Seeking Approval For 50 New Drugs In China
Swiss pharmaceutical giant Novartis has submitted 50 new drugs aimed at treating Asia-specific diseases to Chinese regulators for approval. 
Swiss pharmaceutical giant Novartis has submitted 50 new drugs aimed at treating Asia-specific diseases to Chinese regulators for approval. -
Walgreens Reports Better-Than Expected Fiscal Q3 Earnings
Walgreens Boots Alliance reported better-than-expected fiscal third-quarter earnings bolstered by higher prescription drug sales. 
Walgreens Boots Alliance reported better-than-expected fiscal third-quarter earnings bolstered by higher prescription drug sales.
